Current Drug Targets


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 10 Issue: 1, January

Biomarkers, Critical Disease Pathways, Drug Targets, and Alternative Medicine in Male Breast Cancer

Volume:10   Issue: 1
Pp: 1-8
Debmalya Barh
DOI: 10.2174/138945009787122842
Published on: 01 March, 2012

NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target

Volume:10   Issue: 1
Pp: 9-19
D. M. Sousa, H. Herzog and M. Lamghari
DOI: 10.2174/138945009787122888
Published on: 01 March, 2012

Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events

Volume:10   Issue: 1
Pp: 20-25
S. Novo, M. Lunetta, S. Evola and G. Novo
DOI: 10.2174/138945009787122897
Published on: 01 March, 2012

Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus

Volume:10   Issue: 1
Pp: 26-37
Ewa Robak and Tadeusz Robak
DOI: 10.2174/138945009787122833
Published on: 01 March, 2012

PDGF-D Signaling: A Novel Target in Cancer Therapy

Volume:10   Issue: 1
Pp: 38-41
Zhiwei Wang, Dejuan Kong, Yiwei Li and Fazlul H. Sarkar
DOI: 10.2174/138945009787122914
Published on: 01 March, 2012

Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy – are these Receptors Valid Therapeutic Targets

Volume:10   Issue: 1
Pp: 42-50
Karly C. Sourris and Josephine M. Forbes
DOI: 10.2174/138945009787122905
Published on: 01 March, 2012

HIV: A Raft-Targeting Approach for Prevention and Therapy Using Plant-Derived Compounds (Review)

Volume:10   Issue: 1
Pp: 51-59
S. P. Verma
DOI: 10.2174/138945009787122851
Published on: 01 March, 2012

Pathophysiology of Sepsis in the Elderly: Clinical Impact and Therapeutic Considerations

Volume:10   Issue: 1
Pp: 60-70
A. R. De Gaudio, S. Rinaldi, C. Chelazzi and T. Borracci
DOI: 10.2174/138945009787122879
Published on: 01 March, 2012

Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes

Volume:10   Issue: 1
Pp: 71-87
Rajesh Gupta, Sameer S. Walunj, Ranjeet K. Tokala, Kishore V.L. Parsa, Santosh Kumar Singh and Manojit Pal
DOI: 10.2174/138945009787122860
Published on: 01 March, 2012